National Registry and Cohort Study of Pulmonary Vascular Disease

Conditions studied

Pulmonary Arterial Hypertension

About this study

This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.

Interventions

• Combination Product: The clinical course and disease management — The clinical course and disease management of pulmonary hypertension patients

Primary outcomes

• All-cause Death (5 years)

Eligibility information

Study locations

• Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong China
• Nanjing First Hospital, Nanjing, Jiangsu 210006 China
• General Hospital of Tianjin Medical University, Tianjin, Tianjin Municipality China
• Beijing Anzhen Hospital of Capital Medical University, Beijing, China
• China-japan Friendship Hospital, Beijing, China
• Xiangya Second Hospital, Central South University, Changsha, China
• West China Hospital, Sichuan University, Chendu, China
• Nanjing Drum Tower Hospital, Nanjing, China
• General Hospital of Northen Theater of Command, Shenyang, China
• Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

Showing 10 of 13 reported sites. See the official listing for all locations.